HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.865

+0.1554.18%

Volume:130.00K

Turnover:499.41K

Market Cap:1.66B

PE:-6.26

High:3.910

Open:3.700

Low:3.700

Close:3.710

52wk High:16.800

52wk Low:2.800

Shares:429.00M

HK Float Shares:418.00M

Volume Ratio:2.31

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.618

ROE:-40.11%

ROA:-16.24%

PB:2.27

PE(LYR):-6.26

PS:11.29

Loading ...

Overview Company News Filings

ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy

Bulletin Express

ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer

IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue

Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million

ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed

Bulletin Express

IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed

ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003

ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus

Bulletin Express

ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial

ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial

THOMSON REUTERS

ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation

Bulletin Express

ImmuneOnco Biopharmaceuticals Schedules Board Meeting to Review Interim Results

Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge

Hong Kong Stock Movers: IMMUNEONCO-B (01541) Surges Over 14% as Subsidiary Secures First External Commercial Capital to Accelerate Non-Oncology Pipeline

IMMUNEONCO-B shares surge nearly 10% in afternoon trading after subsidiary raises 50 million yuan

IMMUNEONCO-B's Unit Receives 50 Million Yuan Capital Injection

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/01541/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":3.865,"timestamp":1788140943043,"preClose":3.71,"halted":0,"volume":130000,"delay":0,"changeRate":0.04177897574123996,"floatShares":418000000,"shares":429000000,"eps":-0.6176892620817261,"marketStatus":"Trading","change":0.155,"latestTime":"08-31 09:49:25","open":3.7,"high":3.91,"low":3.7,"amount":499405,"amplitude":0.056604,"askPrice":3.865,"askSize":600,"bidPrice":3.86,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-0.6352840824395523,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788148800000},"marketStatusCode":2,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":3.71,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":2.31202,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":418000000,"roa":"-16.24%","roe":"-40.11%","lyrEps":-0.617689,"volumeRatio":2.31202,"shares":429000000,"dividePrice":0,"high":3.91,"amplitude":0.056604,"preClose":3.71,"low":3.7,"week52Low":2.8,"pbRate":"2.27","psRate":"11.29","week52High":16.8,"institutionHeld":0,"latestPrice":3.865,"committee":0.5,"eps":-0.6176892620817261,"divideRate":0,"volume":130000,"delay":0,"ttmEps":-0.6352840824395523,"open":3.7,"prevYearClose":5.83,"prevWeekClose":3.71,"prevMonthClose":3,"prevQuarterClose":3.87,"fiveDayClose":3.41,"twentyDayClose":3.095,"sixtyDayClose":3.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-08-28","current":-6.083892,"percent":0.783379,"low":-30.003263,"twenty":-16.271167,"median":-9.407815,"eighty":-5.870008,"high":-2.993766,"avg":-11.879695,"sd":7.00379,"marketCap":1594040436},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-06","current":-5.480977,"twenty":-18.467104,"median":-12.547098,"eighty":-6.250095,"marketCap":1868428319},{"date":"2026-02-13","current":-5.764322,"twenty":-18.451463,"median":-12.334661,"eighty":-6.129552,"marketCap":1976305243},{"date":"2026-02-20","current":-5.709616,"twenty":-18.447248,"median":-12.324382,"eighty":-6.122036,"marketCap":1954729858},{"date":"2026-02-27","current":-5.173921,"twenty":-18.36049,"median":-12.246119,"eighty":-6.086335,"marketCap":1790756934},{"date":"2026-03-06","current":-5.567891,"twenty":-18.158064,"median":-12.065853,"eighty":-6.054191,"marketCap":1911579088},{"date":"2026-03-13","current":-6.117869,"twenty":-18.015354,"median":-11.997781,"eighty":-6.054191,"marketCap":2110072628},{"date":"2026-03-20","current":-5.927628,"twenty":-17.916043,"median":-11.941476,"eighty":-6.046952,"marketCap":2036716320},{"date":"2026-03-27","current":-7.775976,"twenty":-17.807771,"median":-11.897801,"eighty":-5.998519,"marketCap":1924524319},{"date":"2026-04-02","current":-8.241979,"twenty":-17.7975,"median":-11.83436,"eighty":-6.013995,"marketCap":2049661551},{"date":"2026-04-10","current":-8.161679,"twenty":-17.786583,"median":-11.824288,"eighty":-6.015601,"marketCap":2045346474},{"date":"2026-04-17","current":-10.223634,"twenty":-17.753464,"median":-11.822864,"eighty":-6.03821,"marketCap":2563155708},{"date":"2026-04-24","current":-8.708527,"twenty":-17.740948,"median":-11.788146,"eighty":-6.050175,"marketCap":2183428936},{"date":"2026-04-30","current":-8.01805,"twenty":-17.720998,"median":-11.771721,"eighty":-6.055393,"marketCap":2010825858},{"date":"2026-05-08","current":-7.201573,"twenty":-17.693999,"median":-11.728007,"eighty":-6.067488,"marketCap":1812332319},{"date":"2026-05-15","current":-6.019771,"twenty":-17.681444,"median":-11.664585,"eighty":-6.067488,"marketCap":1518907086},{"date":"2026-05-22","current":-5.845011,"twenty":-17.559701,"median":-11.603261,"eighty":-6.055393,"marketCap":1471441239},{"date":"2026-05-29","current":-5.00485,"twenty":-17.377503,"median":-11.514742,"eighty":-6.021369,"marketCap":1264317546},{"date":"2026-06-05","current":-5.406956,"twenty":-17.219881,"median":-11.323354,"eighty":-5.987951,"marketCap":1367879393},{"date":"2026-06-12","current":-6.161616,"twenty":-17.185737,"median":-11.281569,"eighty":-5.974648,"marketCap":1557742778},{"date":"2026-06-18","current":-6.148633,"twenty":-17.12503,"median":-11.173523,"eighty":-5.983773,"marketCap":1557742778},{"date":"2026-06-26","current":-6.245478,"twenty":-17.024379,"median":-10.700224,"eighty":-5.984776,"marketCap":1575003086},{"date":"2026-07-03","current":-6.68536,"twenty":-16.923645,"median":-10.487176,"eighty":-5.987546,"marketCap":1687195087},{"date":"2026-07-10","current":-5.923214,"twenty":-16.909148,"median":-10.312858,"eighty":-5.984083,"marketCap":1493016624},{"date":"2026-07-17","current":-5.902209,"twenty":-16.682476,"median":-10.158539,"eighty":-5.968616,"marketCap":1493016624},{"date":"2026-07-24","current":-5.542738,"twenty":-16.623143,"median":-9.958283,"eighty":-5.926348,"marketCap":1402400008},{"date":"2026-07-31","current":-5.106671,"twenty":-16.606785,"median":-9.895629,"eighty":-5.905868,"marketCap":1294523085},{"date":"2026-08-07","current":-5.351615,"twenty":-16.539438,"median":-9.757608,"eighty":-5.872434,"marketCap":1359249239},{"date":"2026-08-14","current":-6.61743,"twenty":-16.502556,"median":-9.567144,"eighty":-5.872434,"marketCap":1682880010},{"date":"2026-08-21","current":-5.73939,"twenty":-16.475236,"median":-9.478992,"eighty":-5.870008,"marketCap":1462811086},{"date":"2026-08-28","current":-5.937689,"twenty":-16.271167,"median":-9.407815,"eighty":-5.870008,"marketCap":1594040436}],"updateTime":1788140965592},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662909679","title":"ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662909679","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662909679?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:01","pubTimestamp":1787925691,"startTime":"0","endTime":"0","summary":"ImmuneOnco nominates Dr. Liou Hsiou-Chi as independent non-executive directorImmuneOnco Biopharmaceuticals (Shanghai) disclosed the planned exit of independent director Zhenping Zhu, effective once a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2q61tP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU0130517989.USD","LU0130518102.USD","BK4553","LU1291159041.SGD","IE0001KFT4U8.USD","BK4588","LU0683600562.USD","LU0306807586.USD","UYG","IE00B1BXHZ80.USD","LU0640476718.USD","LU1366192091.USD","FNCL","TFNS","LU1280957306.USD","BK4504","IYF","LU1804176565.USD","KBWB","XLF","LU0234572021.USD","LU1989771016.USD","LU0130102774.USD","LU1883839398.USD","LU0320765489.SGD","LU1894683264.USD","LU0321505868.SGD","BK4534","LU1201861249.SGD","FTXO","LU0648001328.SGD","LU0130103400.USD","LU0052756011.USD","IYG","LU2133065610.SGD","LU0070302665.USD","LU0980610538.SGD","LU0106831901.USD","BAC","IE0002270589.USD","LU0098860793.USD","LU0053666078.USD","LU0208291251.USD","LU1880398554.USD","01541","LU1162221912.USD","VFH","LU0868494617.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195720547","title":"IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1195720547","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195720547?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837055,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that the Phase II clinical trial evaluating IMM2510 (Peravrafusp alfa) in combination with IMM27M (Tazebsumab) as a first-line treatment for patients with advanced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BMED","COAL","BK1161","MDTX","IBBQ","HCC","IBBJ","PSYK","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194851355","title":"ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1194851355","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194851355?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836918,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has dosed the first patient in its Phase II study evaluating the combination of IMM2510 (palverafusp alfa) and IMM27M...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108812","title":"ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108812","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108812?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836874,"startTime":"0","endTime":"0","summary":"ImmuneOnco doses first patient in Phase II trial of IMM2510-IMM27M combo for first-line advanced liver cancerImmuneOnco dosed the first patient in a Phase II study of IMM2510 with IMM27M as first-line","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbNw7m4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166965470","title":"IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1166965470","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166965470?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:51","pubTimestamp":1787809861,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) rallied sharply during Tuesday afternoon trading, climbing nearly 12% at one point before settling at a 10.27% gain to HK$4.08, with turnover reaching HK$6.239 million....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187887739","title":"Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887739","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187887739?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:00","pubTimestamp":1787799615,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) jumped nearly 12% during Tuesday trading, last up 10.41% at HK$4.085 with turnover reaching HK$3.429 million.The surge follows the company's interim results released on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IBBQ","MDTX","PSYK","BMED","KCAI","BK1161","VXUS","IBBJ","01541","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541","IBBQ","MDTX","PSYK","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708712","title":"ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708712","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:41","pubTimestamp":1787751717,"startTime":"0","endTime":"0","summary":"ImmuneOnco FY26 interim revenue falls 33.2% to RMB 25.4 million; R&D expenses drop 7.9% to RMB 154.8 millionImmuneOnco posted revenue of RMB 25.4 million for the six months ended June 30, 2026, down 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2N6WK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118698746","title":"ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1118698746","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118698746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:47","pubTimestamp":1787654850,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has reported two key advances for its independently developed activin receptor type IIA-Fc fusion protein, IMC-003/IMM72. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192850803","title":"IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1192850803","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192850803?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:44","pubTimestamp":1787654653,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced two significant clinical milestones for IMC-003/IMM72, a proprietary ActRIIA-Fc fusion protein developed by its subsidiary, Immuncare Biopharmaceutical Technology...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4168","IMC","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735417","title":"ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735417","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735417?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:37","pubTimestamp":1787654273,"startTime":"0","endTime":"0","summary":"ImmuneOnco says first PAH patient dosed in Phase Ib/IIa trial of IMC-003ImmuneOnco Biopharmaceuticals (Shanghai) dosed the first patient in a Phase Ib/IIa pulmonary arterial hypertension trial of IMC-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL71fHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119750546","title":"ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1119750546","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119750546?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:45","pubTimestamp":1787316325,"startTime":"0","endTime":"0","summary":"Hong Kong-listed ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) reported that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260429","title":"ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260429?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:07","pubTimestamp":1787314025,"startTime":"0","endTime":"0","summary":"ImmuneOnco wins FDA IND clearance for IMM0306 lupus Phase Ib/II trialFDA cleared an IND for ImmuneOnco’s IMM0306, enabling a Phase Ib/II trial in systemic lupus erythematosus.IMM0306 is a CD47/CD20 bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL5c90g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260410","title":"ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260410?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:06","pubTimestamp":1787313984,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194284340","title":"ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation","url":"https://stock-news.laohu8.com/highlight/detail?id=1194284340","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194284340?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:49","pubTimestamp":1786697340,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. announced that its board of directors will meet on 26 August 2026. The agenda includes: • Reviewing and approving the interim financial results for the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114647","title":"ImmuneOnco Biopharmaceuticals Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114647?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:41","pubTimestamp":1786696903,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals schedules board meeting to review interim resultsImmuneOnco Biopharmaceuticals will hold a board meeting on Aug. 26, 2026 to review interim results for the six months end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL9sJ112:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143946715","title":"Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1143946715","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143946715?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:14","pubTimestamp":1786421692,"startTime":"0","endTime":"0","summary":"The benchmark Hang Seng Index fell 0.63%, dropping 163 points to 25,773 points, while the Hang Seng Tech Index declined 1.27%. Early session turnover on the Hong Kong exchange reached 115.8 billion...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","LU0244354667.USD","LU0634319403.HKD","LU0039217434.USD","HSTECH","LU0228659784.USD","07500","LU0307460666.USD","03032","02833","LU0049853897.USD","SG9999001093.SGD","LU1105468828.SGD","LU1769817179.HKD","LU2226246903.HKD","03033","LU0348825331.USD","LU2097828631.EUR","BK1198","LU0043850808.USD","LU0918141705.HKD","PONY","BK1505","LU0165289439.USD","LU0797268264.HKD","LU1504937902.USD","LU1242518857.USD","83115","LU0588546209.SGD","LU1251922891.USD","LU0274383008.USD","IE0032431581.USD","BK1592","LU1064131342.USD","LU0345780521.USD","LU0348827113.USD","ZIJMY","LU0326950275.SGD","03067","BK1190","LU0509642566.USD","002821","LU0181495838.USD","02493","LU1769817096.USD","LU0737861699.HKD","LU2039709279.SGD","LU1048596156.SGD","06821","LU1303224171.USD","LU0164939612.USD","LU1988902786.USD","LU0821914370.USD","LU0140636845.USD","LU0266512473.USD","LU0469268626.HKD","LU1831875114.USD","LU0082770016.USD","LU0106959298.USD","LU0348814723.USD","LU0417516738.SGD","BK1183","LU0886674414.USD","300759","LU0979878070.USD","HSImain","LU0431992006.USD","BK1170","LU0096374516.USD","LU0266512127.USD","09067","03037","LU2097828474.EUR","HK0000306685.HKD","LU2264538146.SGD","HK0000320264.USD","HTImain","LU0828237510.HKD","07226","LU0417516902.SGD","LU1481107354.HKD","LU0082770016.SGD","BK1109","LU0348767384.USD","LU2399975544.HKD","82800","601899","LU1961090484.USD","HK0000306701.USD","LU0287142896.SGD","BK1129","06616","BK1141","HK0000320223.HKD","LU0918141887.USD","LU2008162690.USD","HHImain","02899","02800","LU2097828557.USD","LU0868486357.SGD","03423","LU0828238088.HKD","LU0871576103.HKD","LU0463099449.HKD","LU1720050803.USD","LU0149721374.USD","ZLAB","03088","LU0329678337.USD","03417","07552","BK1169","SG9999003461.SGD","07200","SG9999004220.SGD","LU0561508036.HKD","LU0531971595.HKD","LU1770034418.SGD","01548","LU1188198961.HKD","LU2460026573.USD","BK1587","LU0164880469.USD","02099","300408","07300","LU0278937759.USD","LU2097828805.USD","LU0620787316.HKD","688234","LU2488822045.USD","03115","688062","LU0061477393.USD","BK1588","LU0828237940.HKD","LU0370786039.SGD","BK1544","09088","MCHmain","HSI","LU0328353924.USD","LU0540923850.HKD","SG9999002463.SGD","LU0348766576.USD","BK1583","01541","LU1282648689.USD","LU0269904917.USD","LU0048580855.USD","513600","BK1576","06951","LU1224709979.USD","LU2177674079.SGD","LU0572944931.SGD","LU0327786744.USD","LU0329678170.USD","BK1594","LU0345780281.USD","LU1794554557.SGD","LU2097828714.EUR","LU0456854461.SGD","BK1161","01651","BK1574","03419","LU1719994722.HKD","02631","03759","LU1808992512.USD","JINFF","LU0348735423.USD","LU1242518931.SGD","02837","LU0211977185.USD","LU0348816934.USD","LU3063872942.SGD","LU0737861772.HKD","09115","LU0173614495.USD","02026","LU0106252389.USD","BK1191","LU0164865239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177678527","title":"Hong Kong Stock Movers: IMMUNEONCO-B (01541) Surges Over 14% as Subsidiary Secures First External Commercial Capital to Accelerate Non-Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177678527","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177678527?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:58","pubTimestamp":1786417095,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) shares surged over 14% in early trading, and as of the time of writing, were up 10.78% to HK$3.495, with a turnover of HK$3.1368 million.On the news front, IMMUNEONCO-B announced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","01541","BK1161","BK4585","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144771177","title":"IMMUNEONCO-B shares surge nearly 10% in afternoon trading after subsidiary raises 50 million yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1144771177","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144771177?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:48","pubTimestamp":1786081695,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) shares jumped nearly 10% in the afternoon session, last trading up 8.42% at HK$3.155, with turnover reaching HK$1.5661 million.The rally follows the company's announcement that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","KCAI","VXUS","01541","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158359504","title":"IMMUNEONCO-B's Unit Receives 50 Million Yuan Capital Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1158359504","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158359504?lang=en_us&edition=fundamental","pubTime":"2026-08-07 07:02","pubTimestamp":1786057338,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that on August 6, 2026, the company, along with its non-wholly owned subsidiary ImmuneCare BiomedTech (Shanghai) Co., Ltd. (the target company), entered into a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK4581","BK4588","BK1161","BK4585","XBI","399441","161726"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}]}}